MEI Pharma, Inc. (MEIP)

[stocking4ms]

I have a big loss on this one "mathew633". I have no choice than to hold for a long... long term.

Company cautious about Pracinostat in AML, won't initiate Phase III clinical trial in mid-2015 as planned:
"...However, we do not intend to initiate any further studies of Pracinostat and azacitidine until we have gained a more complete understanding of the totality of clinical data surrounding the combination. We expect to be in a position to share more information regarding these findings and future development plans for Pracinostat later this year."
http://investor.meipharma.com/2015-03-23-MEI-Pharma-Announces-Top-Line-Data-From-Randomized-Phase-II-Clinical-Study-Of-Pracinostat-In-Front-Line-Myelodysplastic-Syndrome

Other non-Pracinostat studies:
ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors. This study is currently recruiting participants
Estimated Enrollment: 64
Study Start Date: April 2014
Estimated Study Completion Date: August 2015
Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)
https://clinicaltrials.gov/ct2/show/NCT02100007?term=ME-344&rank=1